A somatic point mutation in the KRAS, which is predominantly found in codon 12 (G12V) and 13 (G13D), accounts for about 35–45% of the advanced metastatic stage of CRC (mCRC) (Fernández-Medarde and Santos, 2011) [4]. The gene discussed is KRAS; the disease is colorectal carcinoma.